Silver Point Capital L.P. - 08 Dec 2025 SCHEDULE 13D/A Report for Keenova Therapeutics plc Common Stock, par value $0.01 per share (MNKTQ)

Filing Manager
Silver Point Capital L.P.
Reporting Manager
Silver Point Capital, L.P.
Security
Keenova Therapeutics plc Common Stock, par value $0.01 per share
Symbol
MNKTQ
Shares outstanding
39.5M shares
Disclosed Ownership
4.7M shares
Ownership
11.9%
Form type
SCHEDULE 13D/A
Filing time
10 Dec 2025, 18:29:34 UTC
Date of event
08 Dec 2025
Previous filing
05 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Silver Point Capital, L.P. 11.9% 4.7M 0 4.7M /s/ Steven Weiser Steven Weiser/Authorized Signatory 0001332784
Edward A. Mule 11.9% 4.7M 0 4.7M /s/ Steven Weiser Steven Weiser/Attorney-in-fact 0001029625
Robert J. O'Shea 11.9% 4.7M 0 4.7M /s/ Steven Weiser Steven Weiser/Attorney-in-fact 0001382617